Impact of COVID-19 on HIV late diagnosis in a specialized German centre.

Authors:
van Bremen K; Monin M; Schlabe S; Bischoff J; Rieke GJ and 4 more

Journal:
HIV Med

Publication Year: 2022

DOI:
10.1111/hiv.13426

PMCID:
PMC9874758

PMID:
36263724

View on PubMed View on PMC View Publisher
Journal Information

Full Title: HIV Med

Abbreviation: HIV Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HB…
Gizaw A; King WC; Hinerman AS and 12 more (2022) - Transparency Score: 4/6
Comorbidities in women living with HIV: A systematic review.
Raffe S; Sabin C; Gilleece Y and 2 more (2022) - Transparency Score: 3/6
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A quali…
Courvoisier N; Storari C; Lesage S and 5 more (2022) - Transparency Score: 2/6
High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-lin…
Anderson K; Pietersen E; Shepherd BE and 5 more (2022) - Transparency Score: 3/6
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departm…
Vaz-Pinto I; Gorgulho A; Esteves C and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CB has received honoraria for consulting or educational lectures from abbvie, Bionor, BMS, Gilead, Janssen, MSD, and ViiV. KvB has received honoraria for educational lectures from Virology education and Gilead. JKR has received honoraria for consulting or educational lectures from abbvie, Bionor, BMS, Gilead, Hexal, Janssen, MSD, Roche and ViiV. MM has received honoraria for educational lectures from Virology education and Gilead. Open Access funding enabled and organized by Projekt DEAL."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025